Antonello, R.M.; Principe, L.; Maraolo, A.E.; Viaggi, V.; Pol, R.; Fabbiani, M.; Montagnani, F.; Lovecchio, A.; Luzzati, R.; Di Bella, S.
Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies. Antibiotics 2020, 9, 500.
https://doi.org/10.3390/antibiotics9080500
AMA Style
Antonello RM, Principe L, Maraolo AE, Viaggi V, Pol R, Fabbiani M, Montagnani F, Lovecchio A, Luzzati R, Di Bella S.
Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies. Antibiotics. 2020; 9(8):500.
https://doi.org/10.3390/antibiotics9080500
Chicago/Turabian Style
Antonello, Roberta Maria, Luigi Principe, Alberto Enrico Maraolo, Valentina Viaggi, Riccardo Pol, Massimiliano Fabbiani, Francesca Montagnani, Antonio Lovecchio, Roberto Luzzati, and Stefano Di Bella.
2020. "Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies" Antibiotics 9, no. 8: 500.
https://doi.org/10.3390/antibiotics9080500
APA Style
Antonello, R. M., Principe, L., Maraolo, A. E., Viaggi, V., Pol, R., Fabbiani, M., Montagnani, F., Lovecchio, A., Luzzati, R., & Di Bella, S.
(2020). Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies. Antibiotics, 9(8), 500.
https://doi.org/10.3390/antibiotics9080500